These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20952396)

  • 1. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.
    Simboeck E; Sawicka A; Zupkovitz G; Senese S; Winter S; Dequiedt F; Ogris E; Di Croce L; Chiocca S; Seiser C
    J Biol Chem; 2010 Dec; 285(52):41062-73. PubMed ID: 20952396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
    Mathew OP; Ranganna K; Yatsu FM
    Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
    Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
    J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z.
    Bellucci L; Dalvai M; Kocanova S; Moutahir F; Bystricky K
    PLoS One; 2013; 8(1):e54102. PubMed ID: 23349794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.
    Sun DF; Zhang YJ; Tian XQ; Chen YX; Fang JY
    Cell Biol Int; 2014 Jan; 38(1):50-63. PubMed ID: 24030871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.
    Ju R; Muller MT
    Cancer Res; 2003 Jun; 63(11):2891-7. PubMed ID: 12782595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation.
    Hauser C; Schuettengruber B; Bartl S; Lagger G; Seiser C
    Mol Cell Biol; 2002 Nov; 22(22):7820-30. PubMed ID: 12391151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
    Findeisen HM; Gizard F; Zhao Y; Qing H; Heywood EB; Jones KL; Cohn D; Bruemmer D
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):851-60. PubMed ID: 21233448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
    Oh ET; Park MT; Choi BH; Ro S; Choi EK; Jeong SY; Park HJ
    Invest New Drugs; 2012 Apr; 30(2):435-42. PubMed ID: 20978925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter.
    Nian H; Delage B; Pinto JT; Dashwood RH
    Carcinogenesis; 2008 Sep; 29(9):1816-24. PubMed ID: 18628250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.
    Thakur VS; Gupta K; Gupta S
    Carcinogenesis; 2012 Feb; 33(2):377-84. PubMed ID: 22114073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells.
    To KK; Polgar O; Huff LM; Morisaki K; Bates SE
    Mol Cancer Res; 2008 Jan; 6(1):151-64. PubMed ID: 18234970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
    Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
    Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications and p21-cyclin B1 nexus in anticancer effect of histone deacetylase inhibitors in combination with silibinin on non-small cell lung cancer cells.
    Mateen S; Raina K; Jain AK; Agarwal C; Chan D; Agarwal R
    Epigenetics; 2012 Oct; 7(10):1161-72. PubMed ID: 22965008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
    Richon VM; Sandhoff TW; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation.
    Yang Q; Lu Z; Ramchandran R; Longo LD; Raj JU
    Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(11):L1001-10. PubMed ID: 23043075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression.
    Illi B; Nanni S; Scopece A; Farsetti A; Biglioli P; Capogrossi MC; Gaetano C
    Circ Res; 2003 Jul; 93(2):155-61. PubMed ID: 12805238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
    Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
    Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.